Impact of a Multidisciplinary Consultation Program on Drug Adherence in First Oral Anticancer Treatment

Launched by CENTRE HOSPITALIER UNIVERSITAIRE, AMIENS · Mar 11, 2021

Keywords

ClinConnect Summary

This clinical trial is studying how a special program, called a Multidisciplinary Consultation Program (MCP), can help cancer patients stick to their oral anticancer treatments. These treatments are taken by mouth and can be complicated, often causing side effects that make it hard for patients to follow their medication schedule. The goal of the trial is to see if the MCP improves how well patients adhere to their medication, which is important for the treatment to work effectively.

To be eligible for this trial, participants need to be French-speaking adults who have just been diagnosed with cancer or whose cancer has returned. They cannot be receiving hormone therapy alone or have serious psychiatric disorders. If you or a loved one qualifies, you will be asked to participate in the program and track how well you take your medications before and after the program starts. This research could help improve support for future cancer patients and ensure they receive the best possible care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • French speaking patients with a newly diagnosed or relapsed cancer, regardless of location and introduction of oral anticancer treatment
• Exclusion Criteria:
• • patients treated with hormone therapy only
• • Patient with severe psychiatric disorders
• • patient who does not speak the French language